Weekly Round Up

Research Deep DiveLong Form ArticleWeekly Round Up
Weekly Round UpWeekly Round Up
End of Year Special Issue: A 2025 Review and key Topics for 2026 in Healthcare

End of Year Special Issue: A 2025 Review and key Topics for 2026 in Healthcare

Biotech is projected to cross $2.19T and wearables hit a strategic inflection point, while only 10% of systems report significant AI returns.

Weekly Round UpWeekly Round Up
Beyond the Hype: What Health Systems are Actually Buying for 2026

Beyond the Hype: What Health Systems are Actually Buying for 2026

Hospitals hold 27% of the RCM market and BMS invests $1.5B in CAR T, while 77% of systems stall AI adoption due to maturity issues.

Weekly Round UpWeekly Round Up
75% of Leaders Back AI for Admin, While Biotech Leaves EU 40% Behind

75% of Leaders Back AI for Admin, While Biotech Leaves EU 40% Behind

Precision medicine targets $470B and Sobi bets $1.5B on gout, while small molecules drop to 53% of Phase III trials.

Weekly Round UpWeekly Round Up
FemTech to $130B, a $2B MedTech Move, and a 65% Drop in Late-Stage VC

FemTech to $130B, a $2B MedTech Move, and a 65% Drop in Late-Stage VC

FemTech targets a $130B valuation and Teleflex executes $2B in strategic carve-outs, while late-stage HealthTech funding drops 65% amid a widening global confidence gap.

Weekly Round UpWeekly Round Up
$850B WellTech Boom, $1B Exit, and the New Rules Reshaping U.S. Healthcare

$850B WellTech Boom, $1B Exit, and the New Rules Reshaping U.S. Healthcare

UnitedHealth finalizes its Latin America retreat with a $1B sale to Patria as WellTech surges to an $850B opportunity, while 46 states race to regulate the growing AI adoption gap.

Weekly Round UpWeekly Round Up
The Rise of RPM and AI in Europe: Signals for Healthcare Operators and Investors

The Rise of RPM and AI in Europe: Signals for Healthcare Operators and Investors

RPM adoption is accelerating and AI is reshaping European healthtech, signaling a new investment cycle driven by data, automation, and smarter care delivery.

Weekly Round UpWeekly Round Up
Inside: Nutraceutical Surge, GCC’s Digital Pivot, Home Care Winners

Inside: Nutraceutical Surge, GCC’s Digital Pivot, Home Care Winners

The $1T nutraceuticals market takes center stage as GCC bets big on AI and genomics. Plus, a dive into monitoring PE, the Kenvue deal, and North American home health.

Weekly Round UpWeekly Round Up
Inside Europe’s €440B Pharma Powerhouse: Who’s Winning Big?

Inside Europe’s €440B Pharma Powerhouse: Who’s Winning Big?

Europe’s drug engine still dominates on scale and exports — but lags in innovation speed, regulation, and access. The world’s watching how it adapts.

Weekly Round UpWeekly Round Up
AI Gets Its MD: Why More Docs Are Prescribing Algorithms (and What It Means for You)

AI Gets Its MD: Why More Docs Are Prescribing Algorithms (and What It Means for You)

AI is no longer a healthcare experiment — it’s a daily diagnostic tool. As physicians trade paperwork for algorithms, efficiency is rising, but so are the ethical and operational stakes.

Weekly Round UpWeekly Round Up
Who's Winning The $86.7B Obesity Therepeutics Boom

Who's Winning The $86.7B Obesity Therepeutics Boom

The $86.7B obesity drug boom is redefining healthcare, as pharma giants and investors race to turn a global health crisis into the next trillion-dollar opportunity.

Weekly Round UpWeekly Round Up
The $8.55T Shift Reshaping Healthcare — And What Comes Next

The $8.55T Shift Reshaping Healthcare — And What Comes Next

Value-based care, private equity, and GenAI are redrawing healthcare’s financial map. The next phase isn’t about growth alone—it’s about redefining where and how value is created.

Weekly Round UpWeekly Round Up
The $37B Boom: Can Gamification Really Heal Healthcare?

The $37B Boom: Can Gamification Really Heal Healthcare?

Gamification is transforming patient engagement and digital care—but can it truly heal what healthcare can’t?